首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1186篇
  免费   72篇
  国内免费   11篇
耳鼻咽喉   1篇
儿科学   11篇
妇产科学   82篇
基础医学   136篇
口腔科学   5篇
临床医学   54篇
内科学   90篇
皮肤病学   9篇
神经病学   9篇
特种医学   14篇
外科学   125篇
综合类   110篇
一般理论   1篇
预防医学   499篇
眼科学   1篇
药学   91篇
  1篇
中国医学   11篇
肿瘤学   19篇
  2024年   1篇
  2023年   30篇
  2022年   44篇
  2021年   68篇
  2020年   48篇
  2019年   65篇
  2018年   63篇
  2017年   52篇
  2016年   62篇
  2015年   63篇
  2014年   93篇
  2013年   76篇
  2012年   78篇
  2011年   76篇
  2010年   75篇
  2009年   70篇
  2008年   47篇
  2007年   41篇
  2006年   36篇
  2005年   25篇
  2004年   35篇
  2003年   25篇
  2002年   16篇
  2001年   14篇
  2000年   7篇
  1999年   13篇
  1998年   6篇
  1997年   4篇
  1996年   3篇
  1995年   5篇
  1993年   3篇
  1992年   3篇
  1991年   2篇
  1990年   4篇
  1989年   1篇
  1988年   1篇
  1987年   3篇
  1985年   2篇
  1984年   3篇
  1981年   1篇
  1980年   2篇
  1979年   1篇
  1977年   1篇
  1974年   1篇
排序方式: 共有1269条查询结果,搜索用时 15 毫秒
1.
目的 了解防城港市活禽市场环境禽流感病毒监测情况,为科学评判疫情并采取适当的防控措施提供理论依据。方法 2017年3—4月在全市活禽市场外环境采集笼具擦物、冼禽污水、禽粪、砧板擦物、禽类饮用水等标本,用荧光定量PCR法检测禽流感病毒FluA、H5、H9、H7核酸,并进行统计学分析。结果 采集全市36个活禽市场外环境标本1 855份,阳性393份,阳性率为21.19%,其中H5阳性28份,H7阳性2份,H9阳性198份,H5和H9混合阳性37份,其他亚型(FluA阳性,H5、H7、H9 阴性)128份;不同地区标本阳性率差异有统计学意义(P<0.05);城区和乡镇市场采集的标本的阳性率差异无统计学意义。5种类型的标本中,洗禽污水的阳性率最高,其次是砧板擦物, 再次是禽类饮用水和笼具擦物,禽粪的阳性率最低,差异有统计学意义(P<0.05)。结论 防城港市活禽市场环境普遍存在高致病性禽流感病毒的污染,H9亚型是主要的病原体,采取了综合防控措施后,防城港市没有发生人间禽流感疫情。  相似文献   
2.
《Vaccine》2016,34(45):5436-5441
Influenza is a viral infection that affects much of the global population each year. Vaccination remains the most effective tool for preventing the disease. Live attenuated influenza vaccine (LAIV) has been used since the 1950s to protect humans against seasonal influenza. LAIVs developed by the Institute of Experimental Medicine (IEM), Saint Petersburg, Russia, have been successfully used in Russia since 1987.In 2006, the World Health Organization (WHO) announced a Global action plan for influenza vaccines (GAP). WHO, recognizing potential advantages of LAIV over the inactivated influenza vaccine in a pandemic situation, included LAIV in the GAP.BioDiem Ltd., a vaccine development company based in Melbourne, Australia which held the rights for the Russian LAIV, licensed this technology to WHO in 2009. WHO was permitted to grant sub-licenses to vaccine manufacturers in newly industrialized and developing countries to use the Russian LAIV for the development, manufacture, use and sale of pandemic and seasonal LAIVs. To date, WHO has granted sub-licenses to vaccine manufacturers in China (Changchun BCHT Biotechnology Co., Ltd.), India (Serum Institute of India Pvt. Ltd.) and Thailand (Government Pharmaceutical Organization). In parallel, in 2009, IEM signed an agreement with WHO, under which IEM committed to supply pandemic and seasonal candidate vaccine viruses to the sub-licensees.This paper describes the progress made by collaborators from China, India, Russia and Thailand in developing preventive measures, including LAIV against pandemic influenza.  相似文献   
3.
BackgroundApproximately 7% of breast cancers are diagnosed in women under 40. Question of subsequent fertility has become fundamental. We aimed to evaluate the rate of fertility preservation (FP) by oocyte retrieval (OR) after ovarian stimulation in patients of childbearing age, managed for breast cancer with adjuvant chemotherapy in France, reuse rate of frozen gametes and live births rate (LBR) after treatment.MethodsWe included 15,774 women between 18 and 40 years old, managed by surgery and adjuvant chemotherapy for breast cancer, between January 2011 and December 2020 from a French health registry. Patients with OR after breast surgery and before chemotherapy were considered as FP group; those with no OR as no FP group. To compare LBR with French population independently of age, we calculated Standardized Incidence Rates (SIR) of live births using indirect standardization method.ResultsFP rate increased gradually since 2011, reaching 17% in 2019. A decrease in use was observed in 2020 (13,9%). Among patients with at least 2 years of follow-up, gamete reuse rate was 5,6%. Births after cancer were mostly from spontaneous pregnancies. Among patients with at least 3 years of follow-up, LBR was 19,6% in FP group, 3,9% in second group. SIR of live births was of 1,05 (95% CI = 0.91–1.19) and 0.33 (95% CI = 0.30–0.36) in FP and no FP group respectively.ConclusionOncofertility activity increased until 2019 in France, reaching 17%. Gamete reuse rate was low. Births resulted mainly from spontaneous pregnancies. SIR of live births was lower in no FP group.  相似文献   
4.
目的总结活体亲属肾移植的临床经验。方法对供、受者进行全面的免疫学检查,对供者行IVU检查了解分侧肾功能,行DSA或MRA、螺旋CT血管三维成像检查了解血管的变异情况之后,开放式手术摘取供肾13例,经后腹腔镜活体供肾摘取4例,按常规方法移植给受者。免疫抑制方案为环孢素A(或FK506)、霉酚酸酯(或硫唑嘌呤、雷帕鸣)、强的松三联免疫抑制剂。结果13例开放式手术时间1.5~3.0h,平均2.0h;热缺血时间1.0~1.5min,平均1.2min;术中出血量60~200ml,平均140ml,术中及术后均未输血;术后住院7~10d,平均8d。4例后腹腔镜手术时间3.0~4.5h,平均3.5h;热缺血时间2.5~3.5min,平均2.8min;术中出血量60~100ml,平均75ml,术中及术后均未输血;术后3~5d出院。移植肾血液循环恢复后10~40s泌尿,平均20s。1例受者术后45d发生轻微的急性排斥反应,应用激素冲击3d后逆转,其余受者均无并发症。随访4~60个月,人/肾存活率为100%,移植肾功能良好。结论活体亲属肾移植安全可行,取左肾尽量靠近腹主动脉壁切断肾动脉,取右肾切取少许下腔静脉片。  相似文献   
5.
北京市1989~2002年疫苗相关麻痹型脊髓灰质炎病例的监测   总被引:13,自引:2,他引:11  
北京市急性弛缓性麻痹 (AFP)病例监测系统 1989~ 2 0 0 2年共诊断疫苗相关麻痹型脊髓灰质炎 (脊灰 )(VAPP) 2 0例 ,其中首次服苗VAPP 18例 ,接触服苗VAPP 2例。所有病例均 <2岁 ,<6月龄病例占 85 %。男女发病之比为 9∶1。每年VAPP发生率无明显季节性高峰和地区差异。VAPP总发生率为 1 2 0 / 10 0万剂口服脊灰减毒活疫苗 (OPV)投放量或 1 5 9/ 10 0万剂OPV接种量 ,首次服苗VAPP发生率为 13 18/ 10 0万剂首次服苗量 ,接触服苗VAPP发生率为 0 16 / 10 0万剂OPV接种量。监测结果表明 ,北京市VAPP发生的危险性高于中国其它省份和其它许多国家与地区 ;免疫缺陷和 /或肛门周围脓肿可能是VAPP重要的危险因素。在中国当前尚未改变脊灰疫苗免疫策略的情况下 ,为减少和避免VAPP的发生 ,必须加强接种前儿童病史询问和体检 ,严格掌握接种禁忌证 ;同时要加强对VAPP的监测工作。  相似文献   
6.
This report of the North American Pediatric Transplant Cooperative Study summarizes data contributed by 57 participating centers on 754 children with 761 transplants from 1 January 1989 to 16 February 1989. Data collection was initiated in October 1987 and follow-up of all patients is ongoing. Transplant frequency increased with age; 24% of the patients were less than 5 years, with 7% being under 2 years. Common frequent diagnoses were: aplastic/dysplastic kidneys (18%), obstructive uropathy (16%), and focal segmental glomerulosclerosis (12%). Preemptive transplant, i.e., transplantation without prior maintenance dialysis, was performed in 21% of the patients. Dialytic modalities pretransplant were peritoneal dialysis in 42% and hemodialysis in 25%. Bilateral nephrectomy was reported in 29%. Live-donor sources accounted for 42% of the transplants. Among cadaveric donors, 41% of the donors were under 11 years old. During the first post-transplant month, maintenance therapy was used similarly for live-donor and cadaver source transplants, with prednisone, cyclosporine, and azathioprine used in 93%, 83%, and 81%, respectively. Triple therapy with prednisone, cyclosporine, and azathioprine was used in 78%, 75%, and 75% of functioning cadaver source transplants at 6 months, 12 months, and 18 months as opposed to 60%, 63%, and 54% for live-donor procedures, with single-drug therapy being uncommon. Rehospitalization during months 1–5 occurred in 62% of the patients, with treatment of rejection and infection being the main causes. Additionally, 9% were hospitalized for hypertension. During months 6–12 and 12–17, 30% and 28% of the patients with functioning grafts were rehospitalized. Times to first rejection differed significantly for cadaver and live-donor transplants. The median time to the first rejection was 36 days for cadaver transplants and 156 days for live-donor transplants. Overall, 57% of treated rejections were completely reversible although the complete reversal rate decreased to 37% for four or more rejections. One hundred and fifty-two graft failures had occurred at the time of writing, with a 1-year graft survival estimate of 0.88 for live-donor and 0.71 for cadaver source transplants. In addition to donor source, recipient age is a significant prognostic factor for graft survival. Among cadaver donors, decreasing donor age is associated with a decreasing probability of graft survival. Thirty-five deaths have occurred; 16 attributed to infection and 19 to other causes. The current 1-year survival estimate is 0.94. There have been 9 malignancies.A list of all participating centers and the names of the investigators is printed on pages 552–553  相似文献   
7.
On-site testing of 157 poultry processors disclosed that 50% had three or more abnormal upper extremity findings out of a total of 22 possibles. The average worker had five to six abnormal findings. Impaired pinch strength, decreased vibration sensitivity in the fingertips, and reports of current numbness were the most prevalent. Of workers with signs, 25% reported no symptoms, whereas only 8% of workers reported symptoms but had no signs. The investigators concluded that this measurement method has utility for assessments of worker populations to determine prevalence of CTDs and, potentially, for preclinical detection of these disorders to permit early intervention, reduce medical costs, and minimize disability. The need for accurate measurement to enhance early detection and prevention is discussed.  相似文献   
8.
目的调查广州家禽、家畜批发市场兔、鸭(含雏鸭)、羊、鸡、狗、鸽6种动物的隐孢子虫感染情况。方法取上述动物的粪便292份,用金胺-酚-改良抗酸复染法染色,镜检卵囊。结果检查的6种动物均发现有隐孢子虫感染,自然感染率分别为:64.1%,54.3%(45.0%),21.7%,20.6%,20.0%,14.6%。结论广州家禽、家畜批发市场6种动物存在隐孢子虫感染。  相似文献   
9.
本文以中药学课程为例,从在线教学课程设计、教学实施、教学效果评价、教学反思4个方面论述在线教学模式的构建及实施效果,以期通过总结在线教学的经验,为后续进行混合式教学、提升混合式一流课程建设提供有益借鉴。  相似文献   
10.
背景 育龄期女性胚胎着床失败及流产的最常见原因是胚胎异常,但移植经胚胎种植前遗传学检测(PGT)筛选后的正常胚胎后,仍出现种植失败或流产的原因目前并没有形成统一的结论。目的 分析PGT助孕后种植失败及流产的影响因素。方法 回顾性分析2018年12月至2021年2月在安徽医科大学第一附属医院生殖中心行PGT助孕的329例患者的临床资料,根据患者是否临床妊娠分为临床妊娠组(n=218)和种植失败组(n=111),并将临床妊娠组患者根据妊娠结局分为活产亚组(n=175)和流产亚组(n=43)。比较临床妊娠组和种植失败组,活产亚组和流产亚组的一般情况、促排卵及体外胚胎发育情况。采用多因素Logistic回归分析探讨PGT患者种植失败及流产的影响因素。绘制受试者工作特征(ROC)曲线分析多因素Logistic回归分析筛选出的影响因素对PGT患者发生种植失败及流产的预测价值。结果 多因素Logistic回归分析显示,既往流产次数≥2次〔OR=4.032 0,95%CI(2.423 0,6.710 0)〕、高密度脂蛋白胆固醇(HDL-C)水平低〔OR=3.890 0,95%CI(1.455 0,10...  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号